ArticleOxidative medicine and cellular longevity2022

Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-Resistant Lung Cancer.

Qian Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.